Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients

Lung cancer is still diagnosed at a late stage although novel diagnostic techniques are in use. However, as pharmacogenomics have evolved novel targeted therapies either with tyrosine kinase inhibitors or immunotherapy can be currently used as daily treatment. We present the case of a woman with ana...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Med Case Rep J
Autors principals: Kosmidis, Christoforos, Koimtzis, Georgios, Giannakidis, Dimitrios, Tteralli, Nikos, Mantalovas, Stylianos, Tsakalidis, Alexandros, Tsopouridou, Konstantina, Atmatzidis, Stefanos, Liavas, Lazaros, Zarogoulidis, Paul
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2019
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6333155/
https://ncbi.nlm.nih.gov/pubmed/30666169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S191526
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars